Citations

Clear

7552 citation(s) found for "Ho, Matthew".

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Kondrashova, Olga , Nguyen, Minh , Shield‐Artin, Kristy , Tinker, Anna V. , Teng, Nelson N.H., Harrell, Maria I., Barker, Holly E. , Prakash, Rohit , Kass, Elizabeth M. , Sullivan, Meghan R. , Brunette, Gregory J. , Bernstein, Kara A. , Floquet, Anne , Friedländer, Michael , O’Malley, David M. , Oza, Amit M. , Robillard, Liliane, Maloney, Lara , Bowtell, David D.L. , Giordano, Heidi, Wakefield, Matthew J. , Simmons, Andrew D. , Harding, Thomas C., Raponi, Mitch , McNeish, Iain A. , Swisher, Elizabeth M. , Scott, Clare L. , Lin, Kevin K. , Kaufmann, Scott H. , Kuiper, Michael J. , Ho, Gwo‐Yaw , Jasin, Maria , Sullivan, Meghan R. , Coleman, Robert L. , Kichenadasse, Ganessan , Sun, James X. , Lin, Kevin , McNeish, Iain A , Swisher, Elizabeth M , Friedlander, Michael , Wakefield, Matthew J , Scott, Clare L , Bernstein, Kara A , Kondrashova, Olga , Bowtell, David D , Barker, Holly E , O'Malley, David M

Mayo Clinic

Cancer Discovery | June 6, 2017 | Volume: 7 | Issue: 9 | Pages: 984-998

10.1158/2159-8290.cd-17-0419 | PMID 28588062 Get It

Abstract High-grade epithelial ovarian carcinomas containing mutated BRCA1 or BRCA2 (BRCA1/2) homologous recombination (HR) genes are sensitive to platinum-based chemotherapy and PARP inhibitors (PARPi), while restoration of HR function due to secondary mutations in BRCA1/2 has been recognized as an important resistance mechanism. We sequenced core HR pathway genes in 12 pairs of pretreatment and postprogression tumor biopsy samples collected from patients in ARIEL2 Part 1, a phase II study of the PARPi rucaparib as treatment for platinum-sensitive, relapsed ovarian carcinoma. In 6 of 12 pretreatment biopsies, a truncation mutation in BRCA1, RAD51C, or RAD51D was identified. In five of six paired postprogression biopsies, one or more secondary mutations restored the open reading frame. Four distinct secondary mutations and spatial heterogeneity were observed for RAD51C. In vitro complementation assays and a patient-derived xenograft, as well as predictive molecular modeling, confirmed that resistance to rucaparib was associated with secondary mutations. Significance: Analyses of primary and secondary mutations in RAD51C and RAD51D provide evidence for these primary mutations in conferring PARPi sensitivity and secondary mutations as a mechanism of acquired PARPi resistance. PARPi resistance due to secondary mutations underpins the need for early delivery of PARPi therapy and for combination strategies. Cancer Discov; 7(9); 984–98. ©2017 AACR. See related commentary by Domchek, p. 937. See related article by Quigley et al., p. 999. See related article by Goodall et al., p. 1006. This article is highlighted in the In This Issue feature, p. 920
Pilot report: non-operative treatment of Mayo Type II olecranon fractures in any-age adult patient
Putnam, Matthew D. , Christophersen, Christy, Adams, Julie E. , Adams, Julie , Adams, Julie E

Mayo Clinic

Shoulder & Elbow | June 6, 2017 | Volume: 9 | Issue: 4 | Pages: 285-291

10.1177/1758573217711889 | PMID 28932286 Get It

Background We report on the non-operative treatment of Mayo Type II olecranon fractures. Methods Fourteen isolated Mayo Type II olecranon fractures were treated non-operatively, followed to discharge, and retrospectively reviewed. Treatment was splinting in extension followed by protected active motion beginning 3 weeks to 4 weeks post-injury. Mayo Elbow Performance Index (MEPI) and Shortened Disabilities of the Arm, Shoulder and Hand (QuickDASH) scores were available in 86% and 64% of cases, respectively. Follow-up radiographs were obtained. Results At discharge, the mean (SD) MEPI score was 95 (5). The mean (SD) elbow motion arc was 121° (21°). One patient re-fractured his elbow after discharge by falling on the ice. He recovered after open reduction and internal fixation. One patient (documented Marfan syndrome) developed an asymptomatic non-union. Excepting the patient who fell, no patient received additional care. Conclusions In this pilot report, Mayo Type II olecranon fractures were treated non-operatively to discharge. Good to excellent results were obtained in all patients according to the MEPI. Supportive care of these fractures should be comparatively studied. A downside risk to providing supportive care for these fractures was not identified.
Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease
Bielinski, Suzette J. , Berardi, Cecilia , Decker, Paul A. , Bell, Elizabeth J. , Pankow, James S. , Sale, Michèle M. , Tang, Weihong , Hanson, Naomi Q., Wassel, Christina L. , Budoff, Matthew J. , Sicotte, Hugues , Tsai, Michael Y. , de Andrade, Mariza, Decker, Paul A. , Larson, Nicholas B. , Andrade, Mariza de , Polak, Joseph F. , Bielinski, Suzette , Budoff, Matthew , Pankow, James S , Tang, Weihong

Mayo Clinic

Heart | June 1, 2017 | Volume: 103 | Issue: 15 | Pages: 1185-1193

10.1136/heartjnl-2016-310450 | PMID 28572400 Get It

Objective To determine if hepatocyte growth factor (HGF), a promising biomarker of coronary heart disease (CHD) given its release into circulation in response to endothelial damage, is associated with subclinical and clinical CHD in a racial/ethnic diverse population. Methods HGF was measured in 6738 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Highest mean HGF values (pg/mL) were observed in Hispanic, followed by African, non-Hispanic white, then Chinese Americans. Results In all races/ethnicities, HGF levels were associated with older age, higher systolic blood pressure (SBP) and body mass index, lower high-density lipoprotein, diabetes and current smoking. In fully adjusted models, each SD higher HGF was associated with an average increase in coronary artery calcium (CAC) of 55 Agatston units for non-Hispanic whites (p<0.001) and 51 Agatston units for African-Americans (p=0.007) but was not in the other race/ethnic groups (interaction p=0.02). There were 529 incident CHD events, and CHD risk was 41% higher in African (p<0.001), 17% in non-Hispanic white (p=0.026) and Chinese (p=0.36), and 6% in Hispanic Americans (p=0.56) per SD increase in HGF. Conclusion In a large and diverse population-based cohort, we report that HGF is associated with subclinical and incident CHD. We demonstrate evidence of racial/ethnic heterogeneity within these associations, as the results are most compelling in African-Americans and non-Hispanic white Americans. We provide evidence that HGF is a biomarker of atherosclerotic disease that is independent of traditional risk factors.
Cochlear Implant Electrode Localization Using an Ultra-High Resolution Scan Mode on Conventional 64-Slice and New Generation 192-Slice Multi-Detector Computed Tomography
Carlson, Matthew L. , Witte, Robert J. , Krecke, Karl N. , Grimes, Josh, Koeller, Kelly K. , Bruesewitz, Michael R. , Lane, John I. , Leng, Shuai , Diehn, Felix E. , McCollough, Cynthia H.

Mayo Clinic

Otology & Neurotology | May 31, 2017 | Volume: 38 | Issue: 7 | Pages: 978-984

10.1097/mao.0000000000001463 | PMID 28570418 Get It

Hypothesis: A new generation 192-slice multi-detector computed tomography (MDCT) clinical scanner provides enhanced image quality and superior electrode localization over conventional MDCT. Background: Currently, accurate and reliable cochlear implant electrode localization using conventional MDCT scanners remains elusive. Methods: Eight fresh-frozen cadaveric temporal bones were implanted with full-length cochlear implant electrodes. Specimens were subsequently scanned with conventional 64-slice and new generation 192-slice MDCT scanners utilizing ultra-high resolution modes. Additionally, all specimens were scanned with micro-CT to provide a reference criterion for electrode position. Images were reconstructed according to routine temporal bone clinical protocols. Three neuroradiologists, blinded to scanner type, reviewed images independently to assess resolution of individual electrodes, scalar localization, and severity of image artifact. Results: Serving as the reference standard, micro-CT identified scalar crossover in one specimen; imaging of all remaining cochleae demonstrated complete scala tympani insertions. The 192-slice MDCT scanner exhibited improved resolution of individual electrodes (p < 0.01), superior scalar localization (p < 0.01), and reduced blooming artifact (p < 0.05), compared with conventional 64-slice MDCT. There was no significant difference between platforms when comparing streak or ring artifact. Conclusion: The new generation 192-slice MDCT scanner offers several notable advantages for cochlear implant imaging compared with conventional MDCT. This technology provides important feedback regarding electrode position and course, which may help in future optimization of surgical technique and electrode design.
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma
Pianko, Matthew J. , Funt, Samuel A. , Page, David B. , Cattry, Deepika, Scott, Emma C. , Ansell, Stephen M. , Borrello, Ivan , Gutiérrez, Martín , Lendvai, Nikoletta , Hassoun, Hani , Lesokhin, Alexander M. , Landgren, C Ola , Lesokhin, Alexander M , Landgren, Ola

Mayo Clinic

Leukemia & Lymphoma | May 30, 2017 | Volume: 59 | Issue: 1 | Pages: 221-224

10.1080/10428194.2017.1320713 | PMID 28554253 Get It

Correlation between a 2D channelized Hotelling observer and human observers in a low‐contrast detection task with multislice reading in CT
Yu, Lifeng , Chen, Baiyu , Kofler, James M., Favazza, Christopher , Kupinski, Matthew A. , Favazza, Christopher P, Yu, Lifeng , Leng, Shuai , McCollough, Cynthia H.

Mayo Clinic

Medical Physics | May 28, 2017 | Volume: 44 | Issue: 8 | Pages: 3990-3999

10.1002/mp.12380 | PMID 28555878 Get It

PurposeModel observers have been successfully developed and used to assess the quality of static 2D CT images. However, radiologists typically read images by paging through multiple 2D slices (i.e., multislice reading). The purpose of this study was to correlate human and model observer performance in a low‐contrast detection task performed using both 2D and multislice reading, and to determine if the 2D model observer still correlate well with human observer performance in multislice reading.MethodsA phantom containing 18 low‐contrast spheres (6 sizes × 3 contrast levels) was scanned on a 192‐slice CT scanner at five dose levels (CTDIvol = 27, 13.5, 6.8, 3.4, and 1.7 mGy), each repeated 100 times. Images were reconstructed using both filtered‐backprojection (FBP) and an iterative reconstruction (IR) method (ADMIRE, Siemens). A 3D volume of interest (VOI) around each sphere was extracted and placed side‐by‐side with a signal‐absent VOI to create a 2‐alternative forced choice (2AFC) trial. Sixteen 2AFC studies were generated, each with 100 trials, to evaluate the impact of radiation dose, lesion size and contrast, and reconstruction methods on object detection. In total, 1600 trials were presented to both model and human observers. Three medical physicists acted as human observers and were allowed to page through the 3D volumes to make a decision for each 2AFC trial. The human observer performance was compared with the performance of a multislice channelized Hotelling observer (CHO_MS), which integrates multislice image data, and with the performance of previously validated CHO, which operates on static 2D images (CHO_2D). For comparison, the same 16 2AFC studies were also performed in a 2D viewing mode by the human observers and compared with the multislice viewing performance and the two CHO models.ResultsHuman observer performance was well correlated with the CHO_2D performance in the 2D viewing mode [Pearson product‐moment correlation coefficient R = 0.972, 95% confidence interval (CI): 0.919 to 0.990] and with the CHO_MS performance in the multislice viewing mode (R = 0.952, 95% CI: 0.865 to 0.984). The CHO_2D performance, calculated from the 2D viewing mode, also had a strong correlation with human observer performance in the multislice viewing mode (R = 0.957, 95% CI: 879 to 0.985). Human observer performance varied between the multislice and 2D modes. One reader performed better in the multislice mode (P = 0.013); whereas the other two readers showed no significant difference between the two viewing modes (P = 0.057 and P = 0.38).ConclusionsA 2D CHO model is highly correlated with human observer performance in detecting spherical low contrast objects in multislice viewing of CT images. This finding provides some evidence for the use of a simpler, 2D CHO to assess image quality in clinically relevant CT tasks where multislice viewing is used.
Predictive models in the diagnosis and treatment of autoimmune epilepsy
Dubey, Divyanshu , Singh, Jaysingh , Pittock, Sean J. , Flanagan, Eoin P. , Lennon, Vanda A. , Tillema, Jan‐Mendelt , Shin, Cheolsu, So, Elson, Cascino, Gregory D. , Wingerchuk, Dean M. , Hoerth, Matthew T., Shih, Jerry J. , Nickels, Katherine , McKeon, Andrew , Pittock, S J , Britton, Jeffrey W. , Wirrell, Elaine , So, Elson L., Flanagan, E P , McKeon, Andrew , Dubey, Divyanshu , Nickels, Katherine C

Mayo Clinic

Epilepsia | May 26, 2017 | Volume: 58 | Issue: 7 | Pages: 1181-1189

10.1111/epi.13797 | PMID 28555833 Get It

Summary Objective To validate predictive models for neural antibody positivity and immunotherapy response in epilepsy. Methods We conducted a retrospective study of epilepsy cases at Mayo Clinic (Rochester‐ MN ; Scottsdale‐ AZ , and Jacksonville‐ FL ) in whom autoimmune encephalopathy/epilepsy/dementia autoantibody testing profiles were requested (06/30/2014‐06/30/2016). An Antibody Prevalence in Epilepsy ( APE ) score, based on clinical characteristics, was assigned to each patient. Among patients who received immunotherapy, a Response to Immunotherapy in Epilepsy ( RITE ) score was assigned. Favorable seizure outcome was defined as >50% reduction of seizure frequency at the first follow‐up . Results Serum and cerebrospinal fluid (CSF) from 1,736 patients were sent to the Mayo Clinic Neuroimmunology Laboratory for neural autoantibody evaluation. Three hundred eighty‐seven of these patients met the diagnostic criteria for epilepsy. Central nervous system (CNS)–specific antibodies were detected in 44 patients. Certain clinical features such as new‐onset epilepsy, autonomic dysfunction, viral prodrome, faciobrachial dystonic seizures/oral dyskinesia, inflammatory CSF profile, and mesial temporal magnetic resonance imaging (MRI) abnormalities had a significant association with positive antibody results. A significantly higher proportion of antibody‐positive patients had an APE score ≥4 (97.7% vs. 21.6%, p < 0.01). Sensitivity and specificity of an APE score ≥4 to predict presence of specific neural auto‐antibody were 97.7% and 77.9%, respectively. In the subset of patients who received immunotherapy (77), autonomic dysfunction, faciobrachial dystonic seizures/oral dyskinesia, early initiation of immunotherapy, and presence of antibodies targeting plasma membrane proteins (cell‐surface antigens) were associated with favorable seizure outcome. Sensitivity and specificity of a RITE score ≥7 to predict favorable seizure outcome were 87.5% and 83.8%, respectively. Significance APE and RITE scores can aid diagnosis, treatment, and prognostication of autoimmune epilepsy. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here .
Ileocecal vascularized lymph node transfer for the treatment of extremity lymphedema: A case report
Ciudad, Pedro , Manrique, Oscar J. , Agko, Mouchammed , Liu, En‐Wei , Chang, Wei‐Ling , Yeo, Matthew Sze‐Wei , Huang, Tony Chieh‐Ting , Chilgar, Ram M., Chen, Hung‐Chi , Chen, Hung‐Chi , Mouchammed, Agko , Huang, Tony C T

Mayo Clinic

Microsurgery | May 25, 2017 | Volume: 39 | Issue: 1 | Pages: 81-84

10.1002/micr.30186 | PMID 28543381 Get It

Vascularized lymph node (VLN) transfer has been of high interest in the past decade for the treatment of lymphedema, since it has been shown to be effective in reducing limb volumes, decreasing infectious episodes and improving quality of life. Multiple donor sites have been described in the quest for the optimal one. Herein, we describe a novel lymph node flap option based on the ileocolic artery and vein. The ileocecal vascularized lymph node (IC‐VLN) flap was used in the management of a 33‐year‐old male patient with lower extremity lymphedema secondary to left inguinal trauma. The patient had previously underwent a pedicled omentum flap transposition with minimal improvement in limb size and persistent episodes of infection. At 15 month follow‐up, the IC‐VLN flap improved the lymphatic drainage in the affected limb with a mean limb circumference reduction rate of 26.3%. No donor site complications or further episodes of infection were noted. According to our findings, the IC‐VLN flap may be another option for VLN transfer in very selected cases. Nevertheless, larger series with a longer follow‐up are required to analyze the efficacy and long‐term results of this flap.
Tumor Progression Following Petroclival Meningioma Subtotal Resection: A Volumetric Study
Hunter, Jacob B. , O’Connell, Brendan P., Carlson, Matthew L. , Chambless, Lola, Yawn, Robert J. , Mistry, Akshitkumar M. , Thompson, Reid C., Weaver, Kyle D., Wanna, George B. , Wang, Ray , Hunter, Jacob B

Mayo Clinic

Operative Neurosurgery | May 24, 2017 | Volume: 14 | Issue: 3 | Pages: 215-223

10.1093/ons/opx098 | PMID 28541487 Get It

Abstract BACKGROUND One study has investigated postoperative growth rates following subtotal resection of petroclival meningiomas utilizing linear measurements, which are insensitive to the multidimensional complex growth of meningiomas, to estimate tumor volume. OBJECTIVE To describe petroclival meningioma growth patterns following less-than-complete resection utilizing volumetric analysis and to identify variables associated with tumor progression. METHODS Patients with surgically resected WHO grade I petroclival meningiomas were retrospectively reviewed (1999-2015). Image analysis software was utilized to perform volumetric analyses of tumor size and growth on serial MRI studies. The impact of preoperative and postoperative variables on tumor growth after subtotal resection was analyzed. An increase in tumor volume of at least 20% was defined as “tumor growth.” RESULTS Twenty-three patients had immediate preoperative and serial postoperative MRI studies available for review. The mean preoperative tumor volume was 20.9 cm 3 (range 0.4-54.6). The mean extent of resection was 75.5% (range 31.5%-100.0%). At a mean follow-up of 24.8 mo, 12 tumors (66.7%) exhibited radiological tumor growth, while 6 tumors did not change in size. The median annual volumetric growth rate was 2.82 cm 3 /yr (range –0.34 to 10.1). Extent of resection and immediate postoperative tumor volume were significantly correlated with the annual volumetric growth rate following resection. At last follow-up, 3 (13%) patients required further intervention. CONCLUSION The majority of petroclival meningiomas exhibit growth following subtotal resection. Extent of resection is strongly associated with risk for disease progression following surgery.
Decompressive Hemicraniectomy in the Setting of Poststroke Cerebral Edema: A Case for Early Intervention
Aoun, Rami James N. , Gupta, Aman , Welz, Matthew E., Bendok, Bernard R.

Mayo Clinic

Neurosurgery | May 23, 2017 | Volume: 81 | Issue: 1 | Pages: N11-N13

10.1093/neuros/nyx252 | PMID 28873989 Get It